Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?

Albemarle is set to release its fourth-quarter 2026 earnings report on Feb. 11. Here’s Morningstar’s take on what to look for in Albemarle’s earnings and the outlook for its stock.

Key Morningstar Metrics for Albemarle Stock

• Fair Value Estimate: $200.00
• Morningstar Rating: ★★★
• Morningstar Economic Moat Rating: Narrow
• Morningstar Uncertainty Rating: Very High

Albemarle Earnings Release Date

• Wednesday, Feb. 11, after the close of trading

What to Watch for in Albemarle’s Q4 Earnings

• The biggest thing we will look for is management’s guidance on Albemarle’s realized lithium prices in the first half of 2026. Over the past three months, lithium index spot prices have doubled. So we will look to see how Albemarle’s largely index-referenced pricing strategy translates to realized prices while lithium prices are volatile and moving higher.
• We will also be looking for Albemarle’s costs. In 2025, the firm implemented a cost-cutting plan to reduce unit production costs in response to low lithium prices. We will look to see if Albemarle can keep making progress on its unit cost reduction plan, excluding royalties, which are linked to lithium prices.
• Additionally, we want to hear management’s capital allocation plan now that lithium prices are rising. Management greatly reduced capital expenditures and paused most growth projects in response to low lithium prices. Management said they will remain disciplined going forward, so we want to hear how management will balance the goal of positive free cash flow with growth investment going forward.

Fair Value Estimate for Albemarle

With its 3-star rating, we believe Albemarle’s stock is fairly valued compared with our long-term fair value estimate of $200 per share. We assume roughly a 10% weighted average cost of capital. We use a multiple of 11.5 times midcycle EBITDA to value free cash flows generated beyond our 10-year explicit forecast horizon.

Lithium will remain Albemarle’s largest business. We expect lithium prices to stay at cyclically low levels into 2026. Lithium carbonate spot prices, which tend to be a leading indicator of contract prices, are currently around $9,000 per metric ton (based on published indexes), down from $75,000 at the end of 2022. Prices fell due to rapid supply growth from lower-quality resources, particularly lepidolite in China. However, as demand growth remains strong and global supply growth slows, we expect the market to move from oversupply back to balance by the end of 2026.

Read more about Albemarle’s fair value estimate.

Economic Moat Rating

We award a narrow economic moat rating to Albemarle based on its strong and durable cost advantage in lithium and bromine production. Globally, lithium carbonate is produced from either lower-cost evaporation of brine or higher-cost mining of spodumene minerals. Albemarle has a cost advantage in lithium carbonate production due to its lucrative brine assets in the Salar de Atacama in Chile, which produce lithium at the lowest cost globally, excluding royalties. The firm has a long-term contract through 2043 with the Chilean government to extract around 80,000 metric tons of lithium per year.

Read more about Albemarle’s economic moat.

Financial Strength

Albemarle’s financial health is currently strained. As of Sep. 30, management reported net debt/adjusted EBITDA was 2.1 times, within management’s long-term target of less than 2.5. We expect adjusted EBITDA will fall in the coming quarters due to low lithium prices. Yet, as Albemarle generates positive free cash flow exceeding dividends, we think the company will also pay down debt.

We expect Albemarle’s cost savings and capex reduction will lead to slightlly positive free cash flow in 2025 but come in below the dividend payment. However, Albemarle divested its preferred shares of WR Grace, which will bring around $300 million, which will fund the majority of total dividend payments, including common, preferred, and noncontrolling iterests. Additionally, Albemarle will divest a 51% stake in Ketjen, its catalysts business, to KPS, for $660 million before taxes and fees in a deal that should close in 2026. These actions should support the balance sheet in the near term.

Read more about Albemarle’s financial strength.

Risk and Uncertainty

We assign Albemarle a Very High Uncertainty Rating. The biggest risk for Albemarle is volatile lithium prices. Prices could decline if demand grows more slowly than expected due to slowing EV sales growth. Also, new batteries, such as sodium-ion, could overtake lithium as the preferred energy storage resource.

Lithium production could ramp up more quickly than demand growth if producers bring too much supply to the market. Prices could also remain lower for longer if major battery producers or Chinese state-owned enterprises continue to invest in higher-cost lithium resources to keep the lithium market oversupplied. New lithium production technologies could also alter the cost curve, such as direct lithium extraction. Albemarle faces execution risk in ramping up its new lithium projects, including production delays and cost overruns. Albemarle is also subject to political risk in Chile.

The largest ESG risks come from potential new regulations. Regulations could limit emissions in the bromine business, and the company may not be able to pass along the cost increases. We see this as having a moderate probability and materiality.

Read more about Albemarle’s risk and uncertainty.

ALB Bulls Say

• Albemarle has top-tier lithium assets through its brine operations in Chile and spodumene hard-rock operations in Western Australia, which are among the lowest-cost sources of lithium production globally.
• Lithium prices will rebound then remain well above the marginal cost of production through at least the remainder of the decade, leading to excess profits and return on invested capital for Albemarle.
• Albemarle has low-cost bromine production through its highly concentrated brines in the Dead Sea and Arkansas.

ALB Bears Say

• Lithium prices will fall and remain lower for longer as new supply growth will outpace demand, weighing on profitability. Albemarle’s plans to increase its lithium production capacity will prove value-destructive in the wake of lower prices.
• Albemarle’s weak free cash flow generation will result in the company needing to raise equity in the near future, diluting current shareholders.
• Chile’s plan to nationalize lithium could result in Albemarle being forced to trade a majority stake to the government to renew its lease, destroying shareholder value.

This article was compiled by Rachel Schlueter.